» Articles » PMID: 32859985

XRN2 Interactome Reveals Its Synthetic Lethal Relationship with PARP1 Inhibition

Overview
Journal Sci Rep
Specialty Science
Date 2020 Aug 30
PMID 32859985
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent R-loops (RNA-DNA hybrids with a displaced single-stranded DNA) create DNA damage and lead to genomic instability. The 5'-3'-exoribonuclease 2 (XRN2) degrades RNA to resolve R-loops and promotes transcription termination. Previously, XRN2 was implicated in DNA double strand break (DSB) repair and in resolving replication stress. Here, using tandem affinity purification-mass spectrometry, bioinformatics, and biochemical approaches, we found that XRN2 associates with proteins involved in DNA repair/replication (Ku70-Ku80, DNA-PKcs, PARP1, MCM2-7, PCNA, RPA1) and RNA metabolism (RNA helicases, PRP19, p54(nrb), splicing factors). Novel major pathways linked to XRN2 include cell cycle control of chromosomal replication and DSB repair by non-homologous end joining. Investigating the biological implications of these interactions led us to discover that XRN2 depletion compromised cell survival after additional knockdown of specific DNA repair proteins, including PARP1. XRN2-deficient cells also showed enhanced PARP1 activity. Consistent with concurrent depletion of XRN2 and PARP1 promoting cell death, XRN2-deficient fibroblast and lung cancer cells also demonstrated sensitivity to PARP1 inhibition. XRN2 alterations (mutations, copy number/expression changes) are frequent in cancers. Thus, PARP1 inhibition could target cancers exhibiting XRN2 functional loss. Collectively, our data suggest XRN2's association with novel protein partners and unravel synthetic lethality between XRN2 depletion and PARP1 inhibition.

Citing Articles

Oncogene 5'-3' exoribonuclease 2 enhances epidermal growth factor receptor signaling pathway to promote epithelial-mesenchymal transition and metastasis in non-small-cell lung cancer.

Cheng Y, Wen M, Wang X, Zhu H Cytojournal. 2024; 21:46.

PMID: 39737134 PMC: 11683367. DOI: 10.25259/Cytojournal_49_2024.


Molecular Basis of XRN2-Deficient Cancer Cell Sensitivity to Poly(ADP-ribose) Polymerase Inhibition.

Viera T, Abfalterer Q, Neal A, Trujillo R, Patidar P Cancers (Basel). 2024; 16(3).

PMID: 38339346 PMC: 10854503. DOI: 10.3390/cancers16030595.


PARP inhibitors combined with radiotherapy: are we ready?.

Sun C, Chu A, Song R, Liu S, Chai T, Wang X Front Pharmacol. 2023; 14:1234973.

PMID: 37954854 PMC: 10637512. DOI: 10.3389/fphar.2023.1234973.


Single-molecule imaging of genome maintenance proteins encountering specific DNA sequences and structures.

Irvin E, Wang H DNA Repair (Amst). 2023; 128:103528.

PMID: 37392578 PMC: 10989508. DOI: 10.1016/j.dnarep.2023.103528.


PARP1 associates with R-loops to promote their resolution and genome stability.

Laspata N, Kaur P, Mersaoui S, Muoio D, Liu Z, Bannister M Nucleic Acids Res. 2023; 51(5):2215-2237.

PMID: 36794853 PMC: 10018367. DOI: 10.1093/nar/gkad066.


References
1.
Madabhushi R, Pan L, Tsai L . DNA damage and its links to neurodegeneration. Neuron. 2014; 83(2):266-282. PMC: 5564444. DOI: 10.1016/j.neuron.2014.06.034. View

2.
Aguilera A, Garcia-Muse T . R loops: from transcription byproducts to threats to genome stability. Mol Cell. 2012; 46(2):115-24. DOI: 10.1016/j.molcel.2012.04.009. View

3.
Santos-Pereira J, Aguilera A . R loops: new modulators of genome dynamics and function. Nat Rev Genet. 2015; 16(10):583-97. DOI: 10.1038/nrg3961. View

4.
Richard P, Manley J . Transcription termination by nuclear RNA polymerases. Genes Dev. 2009; 23(11):1247-69. PMC: 2763537. DOI: 10.1101/gad.1792809. View

5.
West S, Gromak N, Proudfoot N . Human 5' --> 3' exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature. 2004; 432(7016):522-5. DOI: 10.1038/nature03035. View